Aditya Roy/AI-Generated Image
What do the BSE-500’s most spectacular winners of the past three years have in common? The answer is clear: cheap valuations. The stocks that delivered outsized gains were those trading at bargain price-to-earnings (P/E) multiples, while the biggest disappointments were often the ones investors had bid up to stratospheric valuations.
Let’s look at the data – and see how this insight can guide smarter investing.
Low valuations powered the top gainers
Over three years, the top 15 performers in the BSE-500 shared one trait: modest P/E ratios at the start. These were not market favourites but overlooked businesses available at low earnings multiples.
| Top 15 gainers (3Y) | 3Y return (%) | P/E 3 years ago |
|---|---|---|
| Mazagon Dock Shipbuilders | 134.80% | 12.7× |
| Neuland Laboratories | 123.50% | 25.5× |
| Rail Vikas Nigam | 118.00% | 5.5× |
| HBL Power Systems | 107.70% | 26.8× |
| Cochin Shipyard | 104.80% | 9.9× |
| Anant Raj | 104.50% | 36.3× |
| Anand Rathi Wealth | 103.70% | 20.1× |
| Godfrey Phillips India | 102.70% | 12.6× |
| Garden Reach Shipbuilders & Engineers | 98.10% | 17.7× |
| Zen Technologies | 96.70% | 143.9× |
| Suzlon Energy | 95.50% | 3.8× |
| Sarda Energy & Minerals | 91.20% | 3.6× |
| Apar Industries | 90.50% | 14.8× |
| MCX | 90.10% | 41.4× |
| HUDCO | 84.50% | 4.0× |
Median P/E (top 15 winners): 14.8×
BSE-500 median P/E (3 years ago): 26.8×
In short, investors who bought quality businesses at sensible valuations enjoyed both earnings growth and market re-rating.
Sky-high valuations plagued the biggest losers
The worst performers were the opposite: once-popular stocks with excessive valuations.
| Top 15 losers (3Y) | 3Y return (%) | P/E 3 years ago |
|---|---|---|
| Tata Elxsi | –14.4% | 84.5× |
| Bandhan Bank | –14.4% | 65.7× |
| Star Health | –14.8% | – |
| Tata Teleservices (Maharashtra) | –18.4% | – |
| Happiest Minds | –18.7% | 71.9× |
| Vedant Fashions | –20.0% | 94.2× |
| Adani Green Energy | –20.3% | 656.0× |
| Campus Activewear | –21.8% | 122.4× |
| Sheela Foam | –23.0% | 58.8× |
| Zee Entertainment | –24.0% | 28.1× |
| Relaxo Footwears | –24.5% | 105.3× |
| Adani Wilmar | –29.3% | 118.0× |
| Aditya Birla Fashion & Retail | –36.7% | 95.5× |
| Adani Energy Solutions | –37.6% | 391.1× |
| Adani Total Gas | –43.1% | 741.6× |
Median P/E (top 15 losers): 95.5×
The contrast is stark. Many of these names were priced for perfection, sometimes hundreds of times earnings, before collapsing when expectations disappointed.
The broader pattern: valuation matters everywhere
This is not unique to India. Globally, “value” stocks (low valuation) have historically outperformed “growth” stocks (high valuation).
- Over the past century, U.S. value stocks beat growth stocks by ~4 per cent annually.
- In 2022, MSCI World Value outperformed MSCI World Growth by 26 percentage points—the widest gap since the dot-com crash.
The principle holds: the cheaper you buy, the better your long-term odds.
The solution: focus on valuation-driven growth
Investors often chase hot narratives. But the evidence shows that starting valuation is the real driver of long-term returns.
Value Research’s stock ratings confirm this: valuation consistently emerges as the top factor behind successful long-term investments.
Proof in action: the long-term growth portfolio
We’ve built this insight into practice with the Value Research Stock Advisor Long-Term Growth Portfolio. It’s a curated set of 11 high-conviction stocks selected for reasonable valuations, strong quality, and healthy growth.
The portfolio at a glance (without names):
| Company | Mcap | P/E | Rating | Quality | Growth | Valuation | Momentum |
|---|---|---|---|---|---|---|---|
| Company A | Mid cap | 19.5× | ★★★★★ | 10 | 6 | 6 | 5 |
| Company B | Large cap | 22.5× | ★★★★ | 8 | 7 | 6 | 4 |
| Company C | Mid cap | 13.2× | ★★★★★ | 10 | 7 | 7 | 9 |
| Company D | Small cap | 16.9× | ★★★★ | 9 | 6 | 7 | 2 |
| Company E | Large cap | 20.6× | ★★★★★ | 9 | 8 | 6 | 8 |
| Company F | Mid cap | 8.6× | ★★★★★ | 9 | 7 | 8 | 3 |
| Company G | Mid cap | 11.7× | ★★★★ | 8 | 7 | 7 | 4 |
| Company H | Small cap | 38.8× | ★★★ | 6 | 6 | 4 | 2 |
| Company I | Small cap | 29.8× | ★★★ | 4 | 5 | 6 | 8 |
| Company J | Small cap | 21.6× | ★★★★★ | 8 | 7 | 7 | 7 |
| Company K | Large cap | 21.5× | ★★★★★ | 9 | 7 | 6 | 5 |
Median P/E: 20.6× vs. BSE-500’s current ~25×
This portfolio represents the most valued from our research universe, quality names with growth potential, trading below the market’s valuation.
Taking action: tilt the odds in your favour
The evidence is overwhelming: valuation is the North Star of long-term investing.
If you want to invest with the same advantage that powered the last three years’ winners, explore our Long-Term Growth Portfolio in Value Research Stock Advisor. With disciplined selection, continuous monitoring, and regular updates, it’s designed to help you capture growth while avoiding costly overvaluation traps.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]





